Technology: AgeTech Companies, Cell-based gene therapy, Cell_Therapies, Stem cell therapy
Industry: End-to-End Drug Development, Longevity Industry 2022, Public
Headquarters: Boston, Massachusetts, United States
Founded Date: 1989-01-01
Employees Number: 1001-5000
Funding Status: IPO
Investor Type: Company
Investment Stage: N/A
Number Of Exits: 2
Acquisitions Number: Made Acquisitions
Investors Number: 9
Total Funding: 536197225
Estimated Revenue: $500M to $1B
Last Funding Date: 2022-05-17
Last Funding Type: Post-IPO Equity

Visit Website
Register and Claim Ownership